{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:55:32Z","timestamp":1764078932248,"version":"3.37.3"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1124\/mol.112.080614","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T04:26:42Z","timestamp":1343276802000},"page":"767-776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Identification of DNA Repair Pathways That Affect the Survival of Ovarian Cancer Cells Treated with a Poly(ADP-Ribose) Polymerase Inhibitor in a Novel Drug Combination"],"prefix":"10.1016","volume":"82","author":[{"given":"Amelia M.","family":"Huehls","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine J.","family":"Huntoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry M.","family":"Karnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.112.080614_bib1","doi-asserted-by":"crossref","first-page":"9377","DOI":"10.1128\/MCB.01229-06","article-title":"Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions","volume":"26","author":"Bartz","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.112.080614_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1158\/1541-7786.MCR-05-0044","article-title":"Development of new EBV-based vectors for stable expression of small interfering RNA to mimick human syndromes: application to NER gene silencing","volume":"3","author":"Biard","year":"2005","journal-title":"Mol Cancer Res"},{"key":"10.1124\/mol.112.080614_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1124\/mol.112.080614_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/422701","article-title":"Chromosomal instability at common fragile sites in Seckel syndrome","volume":"75","author":"Casper","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1124\/mol.112.080614_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol Cell"},{"key":"10.1124\/mol.112.080614_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/carcin\/21.3.453","article-title":"Nucleotide excision repair and human syndromes","volume":"21","author":"de Boer","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1124\/mol.112.080614_bib7","doi-asserted-by":"crossref","first-page":"53ra75","DOI":"10.1126\/scitranslmed.3001538","article-title":"PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors","volume":"2","author":"Dedes","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1124\/mol.112.080614_bib8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1124\/mol.112.080614_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/nar\/gkr748","article-title":"A dual role of BRCA1 in two distinct homologous recombination mediated repair in response to replication arrest","volume":"40","author":"Feng","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.112.080614_bib10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/1078-0432.CCR-11-2189","article-title":"PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy","volume":"18","author":"Fraser","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.112.080614_bib11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"key":"10.1124\/mol.112.080614_bib12","doi-asserted-by":"crossref","first-page":"17276","DOI":"10.1074\/jbc.M011681200","article-title":"Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies","volume":"276","author":"Gatei","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.080614_bib13","doi-asserted-by":"crossref","first-page":"e28862","DOI":"10.1371\/journal.pone.0028862","article-title":"Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil","volume":"6","author":"Geng","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1124\/mol.112.080614_bib14","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1158\/1535-7163.MCT-10-0674","article-title":"Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons","volume":"9","author":"Gmeiner","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/mol.112.080614_bib15","doi-asserted-by":"crossref","unstructured":"Golla RM, Li M, Shen Y, Ji M, Yan Y, Fu K, Greiner TC, McKeithan TW, Chan WC (2011) Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks. Hematol Oncol http:\/\/dx.doi.org\/10.1002\/hon.1020.","DOI":"10.1002\/hon.1020"},{"key":"10.1124\/mol.112.080614_bib16","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.4161\/cc.8.14.8947","article-title":"Cell cycle checkpoint defects contribute to genomic instability in PTEN deficient cells independent of DNA DSB repair","volume":"8","author":"Gupta","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1124\/mol.112.080614_bib17","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1101\/gad.1308805","article-title":"The PTEN\/PI3K pathway governs normal vascular development and tumor angiogenesis","volume":"19","author":"Hamada","year":"2005","journal-title":"Genes Dev"},{"key":"10.1124\/mol.112.080614_bib18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.dnarep.2006.10.016","article-title":"Hypersensitivity phenotypes associated with genetic and synthetic inhibitor-induced base excision repair deficiency","volume":"6","author":"Horton","year":"2007","journal-title":"DNA Repair (Amst)"},{"key":"10.1124\/mol.112.080614_bib19","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1158\/0008-5472.CAN-11-0814","article-title":"Poly(ADP-ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells","volume":"71","author":"Huehls","year":"2011","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.080614_bib20","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/1535-7163.MCT-06-0433","article-title":"Mutation analysis of 24 known cancer genes in the NCI-60 cell line set","volume":"5","author":"Ikediobi","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/mol.112.080614_bib21","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1091\/mbc.e09-04-0303","article-title":"Reduced ATR or Chk1 expression leads to chromosome instability and chemosensitization of mismatch repair-deficient colorectal cancer cells","volume":"20","author":"Jardim","year":"2009","journal-title":"Mol Biol Cell"},{"key":"10.1124\/mol.112.080614_bib22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1124\/mol.105.012716","article-title":"Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival","volume":"68","author":"Karnitz","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.080614_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1741-7015-10-25","article-title":"Advances in using PARP inhibitors to treat cancer","volume":"10","author":"Kummar","year":"2012","journal-title":"BMC Med"},{"key":"10.1124\/mol.112.080614_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.biochem.74.082803.133243","article-title":"DNA mismatch repair","volume":"74","author":"Kunkel","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/mol.112.080614_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/mol.107.034637","article-title":"Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs","volume":"72","author":"Lansiaux","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.080614_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcb.21824","article-title":"The mismatch repair-mediated cell cycle checkpoint response to fluorodeoxyuridine","volume":"105","author":"Liu","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1124\/mol.112.080614_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/mol.112.080614_bib28","doi-asserted-by":"crossref","first-page":"8356","DOI":"10.1128\/MCB.24.19.8356-8365.2004","article-title":"A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment","volume":"24","author":"Luo","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.112.080614_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.gde.2008.01.016","article-title":"DNA repair deficiency as a therapeutic target in cancer","volume":"18","author":"Martin","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"10.1124\/mol.112.080614_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4161\/cc.6.1.3699","article-title":"Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo","volume":"6","author":"Matthews","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1124\/mol.112.080614_bib31","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.080614_bib32","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1158\/0008-5472.CAN-09-4295","article-title":"PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors","volume":"70","author":"McEllin","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.080614_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1158\/1541-7786.MCR-08-0519","article-title":"Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites","volume":"7","author":"McNeill","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1124\/mol.112.080614_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/emmm.200900041","article-title":"Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors","volume":"1","author":"Mendes-Pereira","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1124\/mol.112.080614_bib35","first-page":"5193","article-title":"Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses","volume":"61","author":"Meyers","year":"2001","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.080614_bib36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1124\/mol.110.067199","article-title":"Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in carcinoma cells","volume":"78","author":"Mitchell","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.080614_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/gyno.1996.0163","article-title":"Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy\u2013a randomized phase II study by the Southwest Oncology Group","volume":"61","author":"Muggia","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1124\/mol.112.080614_bib38","first-page":"1477","article-title":"Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo","volume":"30","author":"Nimura","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1124\/mol.112.080614_bib39","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1158\/0008-5472.CAN-03-3040","article-title":"5-Fluoro-2\u2032-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells","volume":"64","author":"Parsels","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.080614_bib40","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1074\/jbc.M111.296475","article-title":"Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes","volume":"287","author":"Patel","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.080614_bib41","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1093\/nar\/gkr563","article-title":"UNG-initiated base excision repair is the major repair route for 5-fluorouracil in DNA, but 5-fluorouracil cytotoxicity depends mainly on RNA incorporation","volume":"39","author":"Pettersen","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.112.080614_bib42","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/1535-7163.MCT-08-0709","article-title":"The role of floxuridine in metastatic liver disease","volume":"8","author":"Power","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/mol.112.080614_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.neo.7900197","article-title":"Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability","volume":"4","author":"Roschke","year":"2002","journal-title":"Neoplasia"},{"key":"10.1124\/mol.112.080614_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cell.2011.03.041","article-title":"Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11","volume":"145","author":"Schlacher","year":"2011","journal-title":"Cell"},{"key":"10.1124\/mol.112.080614_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2006.11.042","article-title":"Essential role for nuclear PTEN in maintaining chromosomal integrity","volume":"128","author":"Shen","year":"2007","journal-title":"Cell"},{"key":"10.1124\/mol.112.080614_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ncb1212","article-title":"The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair","volume":"7","author":"S\u00f8rensen","year":"2005","journal-title":"Nat Cell Biol"},{"key":"10.1124\/mol.112.080614_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s002800050416","article-title":"Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragment formation on S phase progression in HT29 cells","volume":"37","author":"Tang","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/mol.112.080614_bib48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/mol.112.078907","article-title":"Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in mammary tumors","volume":"82","author":"Tang","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.080614_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1101\/gad.13.2.152","article-title":"A role for ATR in the DNA damage-induced phosphorylation of p53","volume":"13","author":"Tibbetts","year":"1999","journal-title":"Genes Dev"},{"key":"10.1124\/mol.112.080614_bib50","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrc1457","article-title":"Hallmarks of \u2018BRCAness\u2019 in sporadic cancers","volume":"4","author":"Turner","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/mol.112.080614_bib51","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1124\/mol.109.055178","article-title":"Cisplatin-induced DNA damage activates replication checkpoint signaling components that differentially affect tumor cell survival","volume":"76","author":"Wagner","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.112.080614_bib52","doi-asserted-by":"crossref","first-page":"15387","DOI":"10.1073\/pnas.2536810100","article-title":"MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation","volume":"100","author":"Wang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.080614_bib53","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1182\/blood-2010-01-265769","article-title":"The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo","volume":"116","author":"Weston","year":"2010","journal-title":"Blood"},{"key":"10.1124\/mol.112.080614_bib54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/emmm.201200229","article-title":"Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53","volume":"4","author":"Williamson","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1124\/mol.112.080614_bib55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1158\/1535-7163.MCT-09-0872","article-title":"ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors","volume":"9","author":"Williamson","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/mol.112.080614_bib56","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1158\/1535-7163.MCT-06-0679","article-title":"Loss of ataxia telangiectasia mutated- and Rad3-related function potentiates the effects of chemotherapeutic drugs on cancer cell survival","volume":"6","author":"Wilsker","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/mol.112.080614_bib57","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00018-008-8557-5","article-title":"Participation of DNA repair in the response to 5-fluorouracil","volume":"66","author":"Wyatt","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/mol.112.080614_bib58","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1016\/S0021-9258(18)47554-0","article-title":"Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death","volume":"262","author":"Yoshioka","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.080614_bib59","doi-asserted-by":"crossref","first-page":"14795","DOI":"10.1073\/pnas.182557299","article-title":"Disruption of the checkpoint kinase 1\/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints","volume":"99","author":"Zhao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.080614_bib60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrc1296","article-title":"Targeting the checkpoint kinases: chemosensitization versus chemoprotection","volume":"4","author":"Zhou","year":"2004","journal-title":"Nat Rev Cancer"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24035508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24035508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.112.080614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T07:58:13Z","timestamp":1740038293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24035508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0026895X24035508"],"URL":"https:\/\/doi.org\/10.1124\/mol.112.080614","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of DNA Repair Pathways That Affect the Survival of Ovarian Cancer Cells Treated with a Poly(ADP-Ribose) Polymerase Inhibitor in a Novel Drug Combination","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.112.080614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}